"From plant to patient, we truly care.™"

PharmaCann Global will be launching a Series B investment round in late Q3 2019.

Our Executive Team, cutting-edge cultivation and research plans, joint ventures with a publicly listed Canadian commercial cannabis producer, and Asia-Pacific operations and sales, are leading the company into its inspiring and lucrative next chapter. We will seek to raise AUD $7M in the global head company.

The Investment Deck will be available shortly. Please leave your details below and we will keep you updated on this exciting opportunity.